Works matching AU Gu, Kangsheng

Results: 37

The efficacy and safety of suvemcitug, envafolimab, and FOLFIRI in microsatellite-stable or mismatch repair–proficient colorectal cancer: preliminary results of a phase 2 study.

Published in:

International Journal of Colorectal Disease, 2025, v. 40, n. 1, p. 1, doi. 10.1007/s00384-025-04806-z

By:

Liu, Ying;
Wang, Jufeng;
Fang, Yong;
Deng, Yanhong;
Hu, Changlu;
Fan, Qingxia;
Gu, Kangsheng;
Zhang, Yu;
Yang, Chen;
Liu, Zhenru;
Tian, Ji;
Sun, Xiyang;
Sun, Shuguang;
Cheng, Ying

Publication type:

Article

The regulatory mechanism of neutrophil extracellular traps in cancer biological behavior.

Published in:

Cell & Bioscience, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13578-021-00708-z

By:

Wang, Hui;
Zhang, Yiyin;
Wang, Qianling;
Wei, Xiaoli;
Wang, Hua;
Gu, Kangsheng

Publication type:

Article

Insulin-like growth factor 1 inhibits autophagy of human colorectal carcinoma drug-resistant cells via the protein kinase B/mammalian target of rapamycin signaling pathway.

Published in:

Molecular Medicine Reports, 2018, v. 17, n. 2, p. 2952, doi. 10.3892/mmr.2017.8272

By:

Wang, Shuomin;
Gu, Kangsheng

Publication type:

Article

Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2).

Published in:

Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28408-3

By:

Xu, Jianming;
Li, Yi;
Fan, Qingxia;
Shu, Yongqian;
Yang, Lei;
Cui, Tongjian;
Gu, Kangsheng;
Tao, Min;
Wang, Xiuwen;
Cui, Chengxu;
Xu, Nong;
Xiao, Juxiang;
Gao, Quanli;
Liu, Yunpeng;
Zhang, Tao;
Bai, Yuxian;
Li, Wei;
Zhang, Yiping;
Dai, Guanghai;
Ma, Dong

Publication type:

Article

Efficacy and Safety of Biosimilar SCT510 Compared with Bevacizumab for the First-Line Treatment of Advanced Non-Squamous Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study.

Published in:

Advances in Therapy, 2024, v. 41, n. 11, p. 4032, doi. 10.1007/s12325-024-02965-z

By:

Cheng, Ying;
Pan, Zhanyu;
Wu, Lin;
Zhu, Bo;
Yu, Yan;
Zang, Kai;
Zhuang, Wu;
Liu, Lianke;
Gu, Kangsheng;
Lian, Juanwen;
Chen, Rixin;
Bian, Tao;
Lin, Dang;
Sun, Shenghua;
Li, Wei;
Hang, Xiaosheng;
Jiang, Ou;
Zhong, Fukuan;
Wang, Rui;
Luo, Hui

Publication type:

Article

Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial.

Published in:

2011

By:

Xu, Binghe;
Jiang, Zefei;
Shao, Zhimin;
Wang, Jiayu;
Feng, Jifeng;
Song, Shuping;
Chen, Zhendong;
Gu, Kangsheng;
Yu, Shiying;
Zhang, Yiping;
Wang, Chuan;
Zhang, Fengchun;
Yang, Junlan

Publication type:

Report

Efficacy and safety of pegylated liposomal doxorubicin and epirubicin as neoadjuvant chemotherapy for breast cancer.

Published in:

Frontiers in Cell & Developmental Biology, 2025, p. 1, doi. 10.3389/fcell.2024.1448037

By:

Shen, Yuanyuan;
Hua, Qingling;
Dong, Menghao;
Jin, Wei;
Hu, Xueyang;
Gu, Kangsheng

Publication type:

Article

mRNA vaccine development and applications: A special focus on tumors (Review).

Published in:

International Journal of Oncology, 2024, v. 65, n. 2, p. N.PAG, doi. 10.3892/ijo.2024.5669

By:

Chen, Bangjie;
Yang, Yipin;
Wang, Xinyi;
Yang, Wenzhi;
Lu, You;
Wang, Daoyue;
Zhuo, Enba;
Tang, Yanchao;
Su, Junhong;
Tang, Guozheng;
Shao, Song;
Gu, Kangsheng

Publication type:

Article

First-line treatment of anti-EGFR monoclonal antibody cetuximab β plus FOLFIRI versus FOLFIRI alone in Chinese patients with RAS/BRAF wild-type metastatic colorectal cancer: a randomized, phase 3 trial.

Published in:

Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02229-4

By:

Shi, Yuankai;
Ba, Yi;
Wang, Junye;
Xiong, Jianping;
Gu, Kangsheng;
Chen, Yigui;
Zheng, Zhendong;
Wang, Zishu;
Guo, Weijian;
Cheng, Ying;
Yin, Xianli;
Liu, Yunpeng;
Bai, Yuxian;
Li, Enxiao;
Li, Qi;
Zhu, Liangjun;
Li, Wei;
Jiang, Da;
He, Jingdong;
Chen, Jiansi

Publication type:

Article

Addition of SHR-1701 to first-line capecitabine and oxaliplatin (XELOX) plus bevacizumab for unresectable metastatic colorectal cancer.

Published in:

Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-02063-0

By:

Qiu, Miao-Zhen;
Bai, Yuxian;
Wang, Jufeng;
Gu, Kangsheng;
Yang, Mudan;
He, Yifu;
Yi, Cheng;
Jin, Yongdong;
Liu, Bo;
Wang, Feng;
Chen, Yu-kun;
Dai, Wei;
Jiang, Yingyi;
Huang, Chuanpei;
Xu, Rui-Hua;
Luo, Hui-Yan

Publication type:

Article

Patients with advanced cancer were treated with immune checkpoint inhibitors and injected with COVID-19 vaccine to improve their prognosis without increasing pancreatic related adverse events.

Published in:

Human Vaccines & Immunotherapeutics, 2024, v. 20, n. 1, p. 1, doi. 10.1080/21645515.2024.2358575

By:

Li, Min;
Liao, Lingling;
Huang, Wei;
Feng, Hui;
Wang, Wanqing;
Huang, Nana;
Zhao, Zhiyan;
Shi, Yu;
Ye, Jinglu;
Gu, Kangsheng

Publication type:

Article

Prognostic value of DNA aneuploidy in gastric cancer: a meta-analysis of 3449 cases.

Published in:

2019

By:

Xu, Jing;
Zhu, Ruolin;
Fan, Lulu;
Ge, Shangqing;
Wei, Wei;
Li, Xiaoqiu;
Da, Liangshan;
Jia, Zhenya;
Zhao, Zhiyan;
Ning, Jie;
Da, Jie;
Peng, Wanren;
Gu, Kangsheng;
Sun, Guoping

Publication type:

journal article

A predictive model for patients with local-regionally advanced oropharyngeal squamous cell carcinoma treated after cervical lymph node dissection.

Published in:

Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 19, p. 17241, doi. 10.1007/s00432-023-05379-6

By:

Xie, Xiaoque;
Kang, Mei;
Qu, Ziting;
Gu, Kangsheng

Publication type:

Article

Diagnostic, Therapeutic Predictive, and Prognostic Value of Neutrophil Extracellular Traps in Patients With Gastric Adenocarcinoma.

Published in:

Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.01036

By:

Zhang, Yiyin;
Hu, Yangyang;
Ma, Cui;
Sun, Hua;
Wei, Xiaoli;
Li, Min;
Wei, Wei;
Zhang, Fei;
Yang, Feng;
Wang, Hua;
Gu, Kangsheng

Publication type:

Article

A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma.

Published in:

Molecular Therapy, 2013, v. 21, n. 7, p. 1456, doi. 10.1038/mt.2013.79

By:

Cui, Chuanliang;
Mao, Lili;
Chi, Zhihong;
Si, Lu;
Sheng, Xinan;
Kong, Yan;
Li, Siming;
Lian, Bin;
Gu, Kangsheng;
Tao, Min;
Song, Xin;
Lin, Tongyu;
Ren, Xiubao;
Qin, Shukui;
Guo, Jun

Publication type:

Article

The effect of liver metastases on clinical efficacy of first‐line programmed death‐1 inhibitor plus chemotherapy in esophageal squamous cell carcinoma: A post hoc analysis of ASTRUM‐007 and meta‐analysis.

Published in:

Cancer Medicine, 2024, v. 13, n. 10, p. 1, doi. 10.1002/cam4.7203

By:

Gao, Jing;
Song, Yan;
Kou, Xiaoge;
Tan, Zhenbo;
Zhang, Shu;
Sun, Meili;
Zhou, Jin;
Fan, Min;
Zhang, Ming;
Song, Yongxiang;
Li, Suyi;
Yuan, Yuan;
Zhuang, Wu;
Zhang, Jingdong;
Zhang, Li;
Jiang, Hao;
Gu, Kangsheng;
Ye, Huangyang;
Ke, Ying;
Qi, Xiao

Publication type:

Article

Immunotherapy progress and clinical strategy of unresectable locally advanced non-small cell lung cancer.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1022042

By:

Xiaofei Zhang;
Jianguo Zhang;
Peiyi Liu;
Juan Wang;
Kuaile Zhao;
Zhengfei Zhu;
Kangsheng Gu;
Weixin Zhao

Publication type:

Article

The Effect of Inflammatory Markers on the Survival of Advanced Gastric Cancer Patients Who Underwent Anti-Programmed Death 1 Therapy.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.783197

By:

Qu, Ziting;
Wang, Qianling;
Wang, Hui;
Jiao, Yang;
Li, Min;
Wei, Wei;
Lei, Yu;
Zhao, Zhiyan;
Zhang, Tengteng;
Zhang, Yiyin;
Gu, Kangsheng

Publication type:

Article

Utilization of circulating cell-free DNA profiling to guide first-line chemotherapy in advanced lung squamous cell carcinoma.

Published in:

Theranostics, 2021, v. 11, n. 1, p. 257, doi. 10.7150/thno.51243

By:

Tao Jiang;
Liyan Jiang;
Xiaorong Dong;
Kangsheng Gu;
Yueyin Pan;
Qin Shi;
Guojun Zhang;
Huijuan Wang;
Xiaochun Zhang;
Nong Yang;
Yuping Li;
Jianping Xiong;
Tienan Yi;
Min Peng;
Yong Song;
Yun Fan;
Jiuwei Cui;
Gongyan Chen;
Wei Tan;
Aimin Zang

Publication type:

Article

METTL3‐mediated the m6A modification of SF3B4 facilitates the development of non‐small cell lung cancer by enhancing LSM4 expression.

Published in:

Thoracic Cancer, 2024, v. 15, n. 11, p. 919, doi. 10.1111/1759-7714.15275

By:

He, Guangsi;
Gu, Kangsheng;
Wei, Jie;
Zhang, Jian

Publication type:

Article

Survival analysis of patients with advanced non‐small cell lung cancer receiving tyrosine kinase inhibitor (TKI) treatment: A multi‐center retrospective study.

Published in:

Thoracic Cancer, 2018, v. 9, n. 2, p. 278, doi. 10.1111/1759-7714.12577

By:

Shi, Qingming;
Guan, Maojing;
Wang, Yong;
Xu, Congjing;
Tang, Lei;
Fu, Wenhua;
Bi, Minghong;
Sun, Xiang;
Gu, Kangsheng;
Pang, Dongsheng

Publication type:

Article

Pembrolizumab versus paclitaxel for previously treated advanced gastric or gastroesophageal junction cancer (KEYNOTE‐063): A randomized, open‐label, phase 3 trial in Asian patients.

Published in:

Cancer (0008543X), 2022, v. 128, n. 5, p. 995, doi. 10.1002/cncr.34019

By:

Chung, Hyun Cheol;
Kang, Yoon‐Koo;
Chen, Zhendong;
Bai, Yuxian;
Wan Ishak, Wan Zamaniah;
Shim, Byoung Yong;
Park, Young Lee;
Koo, Dong‐Hoe;
Lu, Jianwei;
Xu, Jianming;
Chon, Hong Jae;
Bai, Li‐Yuan;
Zeng, Shan;
Yuan, Ying;
Chen, Yen‐Yang;
Gu, Kangsheng;
Zhong, Wen Yan;
Kuang, Shu;
Shih, Chie‐Schin;
Qin, Shu‐Kui

Publication type:

Article

Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first‐line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open‐label, parallel controlled clinical study

Published in:

Cancer Communications, 2022, v. 42, n. 1, p. 3, doi. 10.1002/cac2.12225

By:

Zhang, Jie;
Pan, Yueyin;
Shi, Qin;
Zhang, Guojun;
Jiang, Liyan;
Dong, Xiaorong;
Gu, Kangsheng;
Wang, Huijuan;
Zhang, Xiaochun;
Yang, Nong;
Li, Yuping;
Xiong, Jianping;
Yi, Tienan;
Peng, Min;
Song, Yong;
Fan, Yun;
Cui, Jiuwei;
Chen, Gongyan;
Tan, Wei;
Zang, Aimin

Publication type:

Article

Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study.

Published in:

Cancer Communications, 2021, v. 41, n. 11, p. 1173, doi. 10.1002/cac2.12214

By:

Peng, Zhi;
Liu, Tianshu;
Wei, Jia;
Wang, Airong;
He, Yifu;
Yang, Liuzhong;
Zhang, Xizhi;
Fan, Nanfeng;
Luo, Suxia;
Li, Zhen;
Gu, Kangsheng;
Lu, Jianwei;
Xu, Jianming;
Fan, Qingxia;
Xu, Ruihua;
Zhang, Liangming;
Li, Enxiao;
Sun, Yuping;
Yu, Guohua;
Bai, Chunmei

Publication type:

Article

Safety and activity of WX-0593 (Iruplinalkib) in patients with ALK- or ROS1-rearranged advanced non-small cell lung cancer: a phase 1 dose-escalation and dose-expansion trial.

Published in:

Signal Transduction & Targeted Therapy, 2022, p. 1, doi. 10.1038/s41392-021-00841-8

By:

Shi, Yuankai;
Fang, Jian;
Hao, Xuezhi;
Zhang, Shucai;
Liu, Yunpeng;
Wang, Lin;
Chen, Jianhua;
Hu, Yi;
Hang, Xiaosheng;
Li, Juan;
Liu, Chunling;
Zhang, Yiping;
Wang, Zhehai;
Hu, Yanping;
Gu, Kangsheng;
Huang, Jian'an;
Zhang, Liangming;
Shan, Jinlu;
Ouyang, Weiwei;
Zhao, Yanqiu

Publication type:

Article

MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein.

Published in:

Oncology Letters, 2019, v. 18, n. 2, p. 1607, doi. 10.3892/ol.2019.10496

By:

Wei, Xiaoli;
Gao, Mengru;
Ahmed, Yaser;
Gao, Min;
Liu, Wenbo;
Zhang, Yiyin;
Xie, Xiaoque;
Zhao, Qihong;
Wang, Hua;
Gu, Kangsheng

Publication type:

Article

MicroRNA-200c reverses drug resistance of human gastric cancer cells by targeting regulation of the NER-ERCC3/4 pathway.

Published in:

Oncology Letters, 2019, v. 18, n. 1, p. 145, doi. 10.3892/ol.2019.10304

By:

Li, Min;
Gao, Min;
Xie, Xiaoque;
Zhang, Yiyin;
Ning, Jie;
Liu, Pingping;
Gu, Kangsheng

Publication type:

Article

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.

Published in:

JAMA: Journal of the American Medical Association, 2021, v. 326, n. 10, p. 916, doi. 10.1001/jama.2021.12836

By:

Luo, Huiyan;
Lu, Jin;
Bai, Yuxian;
Mao, Teng;
Wang, Jun;
Fan, Qingxia;
Zhang, Yiping;
Zhao, Kuaile;
Chen, Zhendong;
Gao, Shegan;
Li, Jiancheng;
Fu, Zhichao;
Gu, Kangsheng;
Liu, Zhihua;
Wu, Lin;
Zhang, Xiaodong;
Feng, Jifeng;
Niu, Zuoxing;
Ba, Yi;
Zhang, Helong

Publication type:

Article

Intravenous flurbiprofen axetil can increase analgesic effect in refractory cancer pain.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2009, v. 28, p. 1, doi. 10.1186/1756-9966-28-33

By:

Hongyang Wu;
Zhendong Chen;
Guoping Sun;
Kangsheng Gu;
Yueyin Pan;
Jiqing Hao;
Yingying Du;
Jie Ning

Publication type:

Article

Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer: The ORIENT-16 Randomized Clinical Trial.

Published in:

JAMA: Journal of the American Medical Association, 2023, v. 330, n. 21, p. 2064, doi. 10.1001/jama.2023.19918

By:

Xu, Jianming;
Jiang, Haiping;
Pan, Yueyin;
Gu, Kangsheng;
Cang, Shundong;
Han, Lei;
Shu, Yongqian;
Li, Jiayi;
Zhao, Junhui;
Pan, Hongming;
Luo, Suxia;
Qin, Yanru;
Guo, Qunyi;
Bai, Yuxian;
Ling, Yang;
Yang, Jianwei;
Yan, Zhilong;
Yang, Lei;
Tang, Yong;
He, Yifu

Publication type:

Article

miR-138-5p modulates the expression of excision repair cross-complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin.

Published in:

Oncology Reports, 2019, v. 41, n. 2, p. 1131

By:

Ning, Jie;
Jiao, Yang;
Xie, Xiaoque;
Deng, Xuefei;
Zhang, Yiyin;
Yang, Yuexin;
Zhao, Chenchen;
Wang, Hua;
Gu, Kangsheng

Publication type:

Article

China Anti-Cancer Association (CACA) guidelines for holistic integrative management of lymphoma (version 2022).

Published in:

Holistic Integrative Oncology, 2023, v. 2, n. 1, p. 1, doi. 10.1007/s44178-023-00063-8

By:

Zhang, Qingyuan;
Feng, Jifeng;
Wang, Huaqing;
Huang, Huiqiang;
Zhang, Huilai;
Li, Xiaoqiu;
Gao, Yuhuan;
Song, Yongping;
Li, Zhiming;
Bai, Ou;
Cao, Junning;
Zhou, Hui;
Gu, Kangsheng;
Zhao, Shu;
Zhao, Wenhui;
Qin, Yan;
Li, Yajun;
Ma, Guangyu;
Wen, Shujuan;
Wang, Yu

Publication type:

Article

Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial.

Published in:

Signal Transduction & Targeted Therapy, 2024, p. 1, doi. 10.1038/s41392-024-01948-4

By:

Cui, Jiujie;
Qin, Shukui;
Zhou, Yuhong;
Zhang, Shuang;
Sun, Xiaofeng;
Zhang, Mingjun;
Cui, Jiuwei;
Fang, Weijia;
Gu, Kangsheng;
Li, Zhihua;
Wang, Jufeng;
Chen, Xiaobing;
Yao, Jun;
Zhou, Jun;
Wang, Gang;
Bai, Yuxian;
Xiao, Juxiang;
Qiu, Wensheng;
Wang, Bangmao;
Xia, Tao

Publication type:

Article

Efficacy Assessment and Prognostic Value of Inflammatory Markers in Patients with Stage IV Acral and Cutaneous Melanoma Receiving PD-1 Inhibitors.

Published in:

Journal of Inflammation Research, 2025, v. 18, p. 2531, doi. 10.2147/JIR.S509928

By:

Zhang, Yan;
Qu, Ziting;
Xuan, Han;
Lu, Lili;
Ding, Cuicui;
He, Ziran;
Gu, Kangsheng;
Zhang, Yiyin

Publication type:

Article

A Novel Neutrophil Extracellular Traps Signature for Overall Survival Prediction and Tumor Microenvironment Identification in Gastric Cancer.

Published in:

Journal of Inflammation Research, 2023, v. 16, p. 3419, doi. 10.2147/JIR.S417182

By:

Qu, Ziting;
Han, Yanxun;
Zhu, Qingbo;
Ding, Wenxi;
Wang, Yuyan;
Zhang, Yan;
Wei, Wei;
Lei, Yu;
Li, Min;
Jiao, Yang;
Gu, Kangsheng;
Zhang, Yiyin

Publication type:

Article

Expression changes of ER, PR, HER2, and Ki-67 in primary and metastatic breast cancer and its clinical significance.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1053125

By:

Xueyang Hu;
Wenjun Chen;
Fanfan Li;
Pengfei Ren;
Hongyang Wu;
Congjun Zhang;
Kangsheng Gu

Publication type:

Article

Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1144875

By:

Liangshan Da;
Ziting Qu;
Congjun Zhang;
Yuanyuan Shen;
Wei Huang;
Yiyin Zhang;
Kangsheng Gu

Publication type:

Article